FDA Approves New Flu Vaccine Designed for Seniors

Federal regulators have signed off on a new type of flu vaccine with a booster in it, with the hope of better protecting seniors from the virus.

It’s the first flu vaccine to include what’s called an adjuvant — a compound that helps stimulate the immune system so that a vaccine is more effective.

It’s aimed at people over 65, who typically have a poor immune response to vaccines.

“Immunizing individuals in this age group is especially important because they bear the greatest burden of severe influenza disease and account…

Read the rest of the story from our partners at NBC News.